Vitamin Shoppe Inc (VSI) Receives Average Recommendation of “Hold” from Analysts

Vitamin Shoppe Inc (NYSE:VSI) has been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $5.00.

Several brokerages have weighed in on VSI. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Barclays lowered their price target on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Morgan Stanley reiterated an “equal weight” rating and set a $7.50 price target (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Finally, Zacks Investment Research cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th.

In other Vitamin Shoppe news, major shareholder Vintage Capital Management Llc acquired 133,804 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were acquired at an average cost of $4.28 per share, for a total transaction of $572,681.12. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.07% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. FMR LLC grew its stake in shares of Vitamin Shoppe by 32.4% in the 2nd quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the period. Canada Pension Plan Investment Board boosted its holdings in shares of Vitamin Shoppe by 175.5% in the 3rd quarter. Canada Pension Plan Investment Board now owns 652,600 shares of the specialty retailer’s stock worth $3,491,000 after acquiring an additional 415,700 shares in the last quarter. GMT Capital Corp acquired a new position in shares of Vitamin Shoppe in the 3rd quarter worth approximately $3,423,000. Schwab Charles Investment Management Inc. lifted its holdings in Vitamin Shoppe by 23.5% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 323,786 shares of the specialty retailer’s stock worth $1,733,000 after buying an additional 61,663 shares in the last quarter. Finally, Systematic Financial Management LP lifted its holdings in Vitamin Shoppe by 94.9% during the 3rd quarter. Systematic Financial Management LP now owns 217,345 shares of the specialty retailer’s stock worth $1,163,000 after buying an additional 105,855 shares in the last quarter. Institutional investors own 90.35% of the company’s stock.

Shares of Vitamin Shoppe (NYSE:VSI) traded down $0.05 during midday trading on Monday, hitting $5.25. The company had a trading volume of 1,020,000 shares, compared to its average volume of 613,118. The company has a market cap of $125.88, a P/E ratio of -0.50 and a beta of 0.68. Vitamin Shoppe has a 1-year low of $2.95 and a 1-year high of $23.85. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.20). The business had revenue of $288.20 million for the quarter, compared to the consensus estimate of $297.61 million. Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The firm’s revenue was down 8.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.50 EPS. equities research analysts forecast that Vitamin Shoppe will post 0.34 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Vitamin Shoppe Inc (VSI) Receives Average Recommendation of “Hold” from Analysts” was posted by BBNS and is the property of of BBNS. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/vitamin-shoppe-inc-vsi-receives-average-recommendation-of-hold-from-analysts/1818697.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires


Leave a Reply

 
© 2006-2018 BBNS.